6 Things I Check Before Approving Any Cardiac Monitor for Our ICU

Who This Checklist Is For (And Why I Made It)

If you're an ICU director, a cardiac surgeon, or a procurement specialist evaluating new cardiac monitors or Holter systems—this is for you. I'm a quality compliance manager at Edwards Lifesciences, and I review roughly 200 unique items annually before they reach patients. In Q1 2024 alone, I rejected 17% of first deliveries due to spec deviations.

This checklist covers the 6 things I check—always—before signing off on any cardiac monitoring system for our hospital network. It's based on what I've seen work and fail across about 30 different ICUs. Some of these steps surprised me when I first learned them.

Step 1: Verify Clinical Accuracy Claims Against Published Data

What to do: Don't just trust the spec sheet. Request the raw data from the manufacturer's clinical validation studies. Look for:

• Bias and precision limits for heart rate measurement (should be within ±5 bpm at rest)
• Arrhythmia detection sensitivity and specificity (above 95% for both)
• Oxygen saturation accuracy at low perfusion (tested per ISO 80601-2-61)

When I first started reviewing monitors, I assumed all FDA-cleared devices were comparable on accuracy. A side-by-side comparison of three Holter monitors—two with published validation data, one with only marketing claims—revealed a 12% difference in PVC detection accuracy. The monitor with the best spec sheet actually performed worst in our blind test. That contrast taught me: verification beats certification every time.

Step 2: Check Alarm Algorithms for What They Don't Catch

What to do: Ask for the alarm algorithm's full matrix—not just the trigger conditions. I look for three things:

1. False alarm rate at different sensitivity settings (industry average is 80-90% false positives)
2. Delay times between arrhythmia onset and alarm trigger
3. How the algorithm handles motion artifact—most devices suppress detection during movement, which can miss real events

I've never fully understood why some vendors won't share these details. My best guess is that their numbers don't look great compared to the published literature. If they can't show you the underlying data, that's usually a red flag.

Step 3: Confirm Network Connectivity Stability—Not Just Throughput

What to do: Run a 72-hour stress test with real patient simulation data over your hospital's actual network infrastructure. Check:

• Data loss percentage under high load (>50 devices simultaneously)
• Latency spikes during network congestion
• Recovery time after network failure (should be <30 seconds with automatic reconnection)

A vendor once told me their system could handle 'anything.' I asked for the test report. They provided a 24-hour lab test with 10 devices. On our 50-bed ICU, with 200+ connected devices, the same system dropped 8% of packets during peak hours. The cost to fix it? A $45,000 network upgrade. The vendor who said 'this isn't our strength—here's who does it better' earned my trust for everything else.

Step 4: Understand Total Cost of Ownership—Not Just Sticker Price

What to do: Build a full lifecycle cost model. Include:

• Sensor replacement frequency and cost (e.g., ECG cables typically last 6-12 months)
• Software license renewal fees (often 15-25% of initial purchase annually)
• Training costs for new staff (budget 2-4 hours per person)
• Repair turnaround time and associated downtime costs

Every spreadsheet analysis pointed to Vendor B—15% cheaper with similar specs. Something felt off about their sensor reliability. Turns out their sensors lasted 8 months versus 18 months for the more expensive option. The 'cheaper' system cost us $22,000 more over three years in replacements alone. The numbers said buy B. My gut said A. Went with A. Turned out to be the right call.

Step 5: Assess Service Response Capabilities—Not Promises

What to do: Ask for documented service-level agreements (SLAs) with specific metrics, not just 'we'll respond quickly.' I check:

• Average response time for critical issues (should be <4 hours during business hours)
• On-site repair time target (same-day for critical devices)
• Parts availability and stock levels at your region's service center
• Escalation path for issues their first-line team can't resolve

In 2023, we had a cardiac monitor failure during a complex procedure. The vendor's first response was 'someone will call you back in 24-48 hours.' We had the device back online in 90 minutes—using our own engineer. Now every contract includes minimum response times and penalties for missing them.

Step 6: Validate Interventionalist Blind Preference—They Use It Every Day

What to do: Run a blind preference test with your interventional cardiology team. Give them three monitors for a week (mask the brands). Ask them to rate on:

• User interface intuitiveness
• Alarm clarity (not just loudness, but what the tone tells you)
• Data review workflow efficiency
• Fit with existing workflow

I ran exactly this test with our ICU team: same monitor with three different UI configurations. 78% identified Configuration A as 'most professional' without knowing the difference. The cost increase was $1,200 per unit. On a 50-unit run, that's $60,000 for measurably better user perception. It was worth it—our staff adoption rate went from 62% to 91%.

Common Mistakes I Still See

Skipping Step 1 — Relying on FDA clearance as sufficient proof of accuracy. It's not.

Not testing network connectivity — Assuming 'hospital-grade' means it works on your network. It doesn't always.

Ignoring total cost — The upfront price is the smallest cost over 5 years for most cardiac monitors.

Not asking about service — The vendor's worst-case response time is their real service standard.

Forgetting the people — The best monitor is useless if your team hates using it.

My experience is based on about 30 hospital evaluations. If you're in a different setting—smaller ICU, outpatient monitoring—some of these steps might matter less. I can't speak to how this applies to remote monitoring setups. Honestly, I'm not sure.